Thursday, October 15, 2026
BTC $80,544 ▼ 1.27%
Subscribe
Menu
NewsLive WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
MoreDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
LIVE
ADA$0.220down−4.33%ETH$2,350down−2.85%LINK$12.00down−3.42%SOL$101.72down−2.37%BTC$80,544down−1.27%XRP$1.30down−2.53%S&P 5007,719down−1.11%Nasdaq26,693down−1.88%Dow51,621down−0.09%RUT2,730down−1.93%TNX5.19%down−0.52%TYX5.53%down−0.68%FVX4.99%down−0.30%IRX4.08%up+0.69%VIX16.87up+10.48%GOLD$4,158.50up+1.23%SILVER$56.06up+0.32%OIL$94.07down−1.07%DXY102.07down−0.47%NVDA$221.30down−3.16%AAPL$342.96up+0.50%TSLA$367.16down−2.15%META$737.54down−3.27%MSFT$533.69down−1.80%AMZN$254.08down−1.74%GOOGL$347.64down−1.74%Fear & Greed53 — NeutralADA$0.220down−4.33%ETH$2,350down−2.85%LINK$12.00down−3.42%SOL$101.72down−2.37%BTC$80,544down−1.27%XRP$1.30down−2.53%S&P 5007,719down−1.11%Nasdaq26,693down−1.88%Dow51,621down−0.09%RUT2,730down−1.93%TNX5.19%down−0.52%TYX5.53%down−0.68%FVX4.99%down−0.30%IRX4.08%up+0.69%VIX16.87up+10.48%GOLD$4,158.50up+1.23%SILVER$56.06up+0.32%OIL$94.07down−1.07%DXY102.07down−0.47%NVDA$221.30down−3.16%AAPL$342.96up+0.50%TSLA$367.16down−2.15%META$737.54down−3.27%MSFT$533.69down−1.80%AMZN$254.08down−1.74%GOOGL$347.64down−1.74%Fear & Greed53 — Neutral
Tag

eli lilly

5 articles

Eli Lilly's Retatrutide Shows 20.8% Weight Loss at Top Dose; BLA Due Q1 2027
U.S. Equities15d ago
Eli Lilly's Retatrutide Shows 20.8% Weight Loss at Top Dose; BLA Due Q1 2027
Triple agonist achieves dose-dependent weight reductions up to 49.6 pounds and A1C drops to 5.7% in 40% of patients, clearing path for 2027 market entry.
17 S&P 500 Companies Drive Index Returns on Margin Expansion
U.S. Equities65d ago
17 S&P 500 Companies Drive Index Returns on Margin Expansion
A core group of 17 S&P 500 constituents is outpacing the broader market through disciplined cost control and expanding profit margins, deepening index concentration since 2020.
Eli Lilly Surges 6.5% on Q2 Beat; Nvidia Holds AI Chip Lead
U.S. Equities65d ago
Eli Lilly Surges 6.5% on Q2 Beat; Nvidia Holds AI Chip Lead
Eli Lilly topped second-quarter estimates and Nvidia extended its lead in AI chips as broad indexes logged a fifth straight winning session.
AMD, Eli Lilly Earnings Will Test Whether the Rally Can Broaden
U.S. Equities74d ago
AMD, Eli Lilly Earnings Will Test Whether the Rally Can Broaden
The Nasdaq rose 1.0 percent Tuesday while the Russell 2000 fell 0.5 percent, a split that puts pressure on next week's earnings to justify current valuations.
Eli Lilly's Retatrutide FDA Bid Targets $25B Peak Sales in $100B Obesity Market
U.S. Equities83d ago
Eli Lilly's Retatrutide FDA Bid Targets $25B Peak Sales in $100B Obesity Market
Lilly's triple-receptor weight-loss drug retatrutide heads to FDA with a 24 percent efficacy edge over rivals and a $1,200 price target from JPMorgan.